S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Laurence H. Baker, DO, FACOI
University of Michigan Rogel Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
113 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- East Bay Radiation Oncology Center
Castro Valley, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Epic Care-Dublin
Dublin, California, United States
- Bay Area Breast Surgeons Inc
Emeryville, California, United States
- Epic Care Partners in Cancer Care
Emeryville, California, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Los Angeles County-Usc Medical Center
Los Angeles, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- El Camino Hospital
Mountain View, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Bay Area Tumor Institute
Oakland, California, United States
- Hematology and Oncology Associates-Oakland
Oakland, California, United States
- Highland General Hospital
Oakland, California, United States
- Doctors Medical Center- Jc Robinson Regional Cancer Center
San Pablo, California, United States
- Illinois Cancercare-Bloomington
Bloomington, Illinois, United States
- Saint Joseph Medical Center
Bloomington, Illinois, United States
- Illinois Cancercare-Canton
Canton, Illinois, United States
- Memorial Hospital of Carbondale
Carbondale, Illinois, United States
- Illinois Cancercare-Carthage
Carthage, Illinois, United States
- Centralia Oncology Clinic
Centralia, Illinois, United States
- Cancer Care Center of Decatur
Decatur, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Heartland Cancer Research Ncorp
Decatur, Illinois, United States
- Crossroads Cancer Center
Effingham, Illinois, United States
- Illinois Cancercare-Eureka
Eureka, Illinois, United States
- Little Company of Mary Hospital
Evergreen Park, Illinois, United States
- Illinois Cancercare-Galesburg
Galesburg, Illinois, United States
- Western Illinois Cancer Treatment Center
Galesburg, Illinois, United States
- Illinois Cancercare-Kewanee Clinic
Kewanee, Illinois, United States
- Illinois Cancercare-Macomb
Macomb, Illinois, United States
- Illinois Cancercare-Ottawa Clinic
Ottawa, Illinois, United States
- Radiation Oncology of Northern Illinois
Ottawa, Illinois, United States
- Illinois Cancercare-Pekin
Pekin, Illinois, United States
- Osf Saint Francis Radiation Oncology at Pekin Cancer Treatment Center
Pekin, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Methodist Medical Center of Illinois
Peoria, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Nov 2011
- Primary completion
- 1 May 2018
- Completion
- 8 Apr 2019
- Last update posted
- 15 Dec 2022
- Registered enrollment
- 146
- Registry id
- NCT01416688
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.